Combination of Danshen and ligustrazine has dual anti-inflammatory effect on macrophages and endothelial cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of Danshen and ligustrazine has dual anti-inflammatory effect on macrophages and endothelial cells
Authors
Keywords
Danshen, Ligustrazine, Inflammation, RNA-Seq, IL-6
Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 266, Issue -, Pages 113425
Publisher
Elsevier BV
Online
2020-10-01
DOI
10.1016/j.jep.2020.113425
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease
- (2020) Luca Liberale et al. EUROPEAN HEART JOURNAL
- Effect of Danshen on TLR2-triggered inflammation in macrophages
- (2020) Tingting Ye et al. PHYTOMEDICINE
- IL-6: linking chronic inflammation and vascular calcification
- (2019) Raquel López-Mejías et al. Nature Reviews Rheumatology
- Ataxin-3 Links NOD2 and TLR2 Mediated Innate Immune Sensing and Metabolism in Myeloid Cells
- (2019) Thomas P. Chapman et al. Frontiers in Immunology
- RNA-sequencing based bone marrow cell transcriptome analysis reveals the potential mechanisms of E'jiao against blood-deficiency in mice
- (2019) Yan Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Non-proteolytic calpain-6 interacts with VEGFA and promotes angiogenesis by increasing VEGF secretion
- (2019) Mijung Oh et al. Scientific Reports
- Atherosclerosis and immunity: a perspective
- (2018) Fereshte Abdolmaleki et al. TRENDS IN CARDIOVASCULAR MEDICINE
- The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction
- (2018) Veronika Szentes et al. Frontiers in Immunology
- The prognostic value of interleukin 6 in multiple chronic diseases and all-cause death: The Multi-Ethnic Study of Atherosclerosis (MESA)
- (2018) Miguel Cainzos-Achirica et al. ATHEROSCLEROSIS
- Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion
- (2017) Vahid Tavakolian Ferdousie et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Danshen injection prevents heart failure by attenuating post-infarct remodeling
- (2017) Lingyan Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Effect of Salvia miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury
- (2016) Wendong Huang et al. Molecular Medicine Reports
- NOD-Like Receptors in Infection, Immunity, and Diseases
- (2016) Young Keun Kim et al. YONSEI MEDICAL JOURNAL
- Role of Inflammatory Cells and Toll-Like Receptors in Atherosclerosis
- (2015) Anusha Seneviratne et al. Current Vascular Pharmacology
- Ligustrazine monomer against cerebral ischemia-reperfusion injury
- (2015) Qing-chun Mu et al. Neural Regeneration Research
- Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
- (2014) Enrica Golia et al. Current Atherosclerosis Reports
- Vascular cell adhesion molecule-1 (VCAM-1)-An increasing insight into its role in tumorigenicity and metastasis
- (2014) Martin Schlesinger et al. INTERNATIONAL JOURNAL OF CANCER
- Toll-like receptors in atherosclerosis: a ‘Pandora's box’ of advances and controversies
- (2013) Jennifer E. Cole et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Signaling in Innate Immunity and Inflammation
- (2012) K. Newton et al. Cold Spring Harbor Perspectives in Biology
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- Tumor necrosis factor receptor cross-talk
- (2011) Petrus J. W. Naudé et al. FEBS Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started